Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Clinical trial NCT04445987 · COMPLETED
Trial details
- NCT number
- NCT04445987
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-12
- Primary completion
- 2022-11-19
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.